The Effect of Long-Term Low-Dose Atropine on Refractive Progression in Myopic Australian School Children
Myopia will affect half the global population by 2050 and is a leading cause of vision impairment. High-dose atropine slows myopia progression but with undesirable side-effects. Low-dose atropine is an alternative. We report the effects of 0.01% or 0.005% atropine eye drops on myopia progression in...
Main Authors: | William Myles, Catherine Dunlop, Sally A. McFadden |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-04-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/10/7/1444 |
Similar Items
-
Is 0.01% Atropine an Effective and Safe Treatment for Myopic Children? A Systemic Review and Meta-Analysis
by: Hou-Ren Tsai, et al.
Published: (2021-08-01) -
Atropine 0.01% eye drops slow myopia progression: a systematic review and Meta-analysis
by: Ying Zhao, et al.
Published: (2019-08-01) -
The Effect of 0.01% Atropine Eye Drops on the Ocular Surface in Children for the Control of Myopia—The Primary Results from a Six-Month Prospective Study
by: Cheng J, et al.
Published: (2020-08-01) -
Meta-analysis of 0.01% Atropine for Asian adolescents and children of low and medium myopia in diopter and axial length
by: Hao-Bo Fan, et al.
Published: (2021-05-01) -
The Combined Effect of Low-dose Atropine with Orthokeratology in Pediatric Myopia Control: Review of the Current Treatment Status for Myopia
by: José-María Sánchez-González, et al.
Published: (2020-07-01)